Gilead now own the rights to Sprint's preclinical oncology immunotherapy programme, which targets the novel cancer target, ...

Developed by UCL spinout Autolus, Aucatzyl will be launched imminently across England and Wales. A UK-developed cell therapy ...

At the 2025 Veeva Commercial Summit Europe, experts touted the benefits of AI but stressed the importance of data and ...

Made Scientific and Cellergy Therapeutics have formed a partnership to advance CLG-001 mitochondrial therapy towards in-human ...

Novartis has received approval from the US Food and Drug Administration (FDA) for the Itvisma gene replacement therapy to ...